Till now, the anti-inflammatory effects of GLP-1R agonist have been confirmed in different diseases, such as renal injury [28], atherosclerosis [29], type 2 diabetes mellitus [30], and intracerebral hemorrhage [31]. This evidence concerns the gene GLP1R and diabetes mellitus.